The safety and efficacy of hydroxyurea in 2 to 5 year old children with sickle cell disease

被引：0
|
作者：
Hoppe, C [1 ]
Van Warmerdam, J [1 ]
Allen, K [1 ]
Quirolo, K [1 ]
Vichinsky, E [1 ]
Styles, L [1 ]
机构：
[1] Childrens Hosp Oakland, Oakland, CA USA
来源：
PEDIATRIC RESEARCH | 1999年 / 45卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
859
引用
下载
收藏
页码：147A / 147A
页数：1
相关论文
共 50 条
  • [31] Role of hydroxyurea (HU) in children with sickle cell disease (SCD)
    Motwani, J
    Lawson, SE
    Darbyshire, PJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 24 - 25
  • [32] Alterations in the Humoral Immunophenotype of Children with Sickle Cell Disease on Hydroxyurea
    Vistica-Sampino, Emily
    Chorzalska, Anna D.
    Bonal, Dennis M.
    Morgan, John
    Nguyen, Lisa
    Rodriguez, Anaelena
    Lulla, Rishi
    Dubielecka, Patrycja M.
    BLOOD, 2022, 140 : 2523 - 2525
  • [33] Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease
    Pashankar, Farzana D.
    Manwani, Deepa
    Lee, Margaret T.
    Green, Nancy S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (03) : 242 - 243
  • [34] Genetic Predictors of Hydroxyurea Response in Children with Sickle Cell Disease
    McDade, Jenny
    Flanagan, Jonathan M.
    Mortier, Nicole
    Smeltzer, Matthew
    Howard, Thad A.
    Cone, Amy
    Hankins, Jane
    Aygun, Banu
    Wu, Song
    Ware, Russell E.
    BLOOD, 2009, 114 (22) : 338 - 338
  • [35] When Should Hydroxyurea Be Used for Children With Sickle Cell Disease?
    Mueller, Brigitta U.
    PEDIATRICS, 2008, 122 (06) : 1365 - 1366
  • [36] Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease
    Telen, Marilyn J.
    BLOOD, 2016, 127 (07) : 810 - 819
  • [37] INTERIM SAFETY AND EFFICACY OF VOXELOTOR IN CHILDREN AGED 2 to <4 YEARS WITH SICKLE CELL DISEASE
    Fuh, Beng
    Inati, Adlette
    Inusa, Baba
    Abboud, Miguel
    Norris, Cynthia
    Kalpatthi, Ramasubramanian
    Telfer, Paul
    Trompeter, Sara
    Dixon, Sandy
    Enriquez, Aimee
    Akhlaghi, Fatemeh
    Smith-Whitley, Kim
    Brown, Clark
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S163 - S164
  • [38] Consent, compliance, toxicity and efficacy of hydroxyurea therapy in sickle cell disease
    Hilliard, LM
    Schwartz, J
    Collins, HC
    Howard, TH
    PEDIATRIC RESEARCH, 2003, 53 (04) : 277A - 277A
  • [39] SAFETY AND EFFICACY OF HYDROXYUREA IN CHILDREN AND ADOLESCENTS WITH SICKLE/BETA-THALASSEMIA: THE GREEK EXPERIENCE
    Papadopoulou, E.
    Economou, M.
    Teli, A.
    Zafeiriou, D.
    Athanassiou-Metaxa, M.
    Gompakis, N.
    Papachristou, F.
    HAEMATOLOGICA, 2012, 97 : 168 - 168
  • [40] HYDROXYUREA FOR SICKLE-CELL DISEASE
    ROWE, PM
    LANCET, 1995, 345 (8945): : 311 - 311
12345